Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)
31.52
+1.37 (4.54%)
Mar 10, 2026, 11:29 AM CST
SHA:688321 Revenue
In the year 2025, Shenzhen Chipscreen Biosciences had annual revenue of 909.54M CNY with 38.24% growth. Shenzhen Chipscreen Biosciences had revenue of 235.38M in the quarter ending December 31, 2025, with 33.11% growth.
Revenue
909.54M
Revenue Growth
+38.24%
P/S Ratio
14.68
Revenue / Employee
858.05K
Employees
973
Market Cap
13.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 909.54M | 251.59M | 38.24% |
| Dec 31, 2024 | 657.95M | 134.24M | 25.63% |
| Dec 31, 2023 | 523.71M | -6.23M | -1.18% |
| Dec 31, 2022 | 529.94M | 99.49M | 23.11% |
| Dec 31, 2021 | 430.45M | 160.98M | 59.74% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Beijing Aosaikang Pharmaceutical | 1.83B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 2.72B |
| Shanghai Haoyuan Chemexpress | 2.87B |
| Zhejiang Jingxin Pharmaceutical | 4.00B |
| ApicHope Pharmaceutical Group | 1.02B |
| Shanghai Shyndec Pharmaceutical | 9.36B |
| Guangdong Taienkang Pharmaceutical | 674.49M |
| Guobang Pharma | 5.94B |